Outcomes of activated prothrombin complex concentrate for direct Xa inhibitor bleeding

Thromb Res. 2021 Oct:206:142-144. doi: 10.1016/j.thromres.2021.08.011. Epub 2021 Aug 17.
No abstract available

Keywords: Anticoagulants; Apixaban; Bleeding; FEIBA; Reversal; Rivaroxaban.

MeSH terms

  • Administration, Oral
  • Anticoagulants / adverse effects
  • Blood Coagulation Factors* / therapeutic use
  • Factor VIIa / therapeutic use
  • Factor Xa Inhibitors / therapeutic use
  • Hemorrhage* / chemically induced
  • Hemorrhage* / drug therapy
  • Humans
  • Pyridones / therapeutic use
  • Rivaroxaban / therapeutic use

Substances

  • Anticoagulants
  • Blood Coagulation Factors
  • Factor Xa Inhibitors
  • Pyridones
  • prothrombin complex concentrates
  • Rivaroxaban
  • Factor VIIa